https://www.selleckchem.com/pr....oducts/LY315920(Vare
Objective Current research validates the use of lithium as a first-line agent in bipolar disorder, yet it remains underutilized. This might, in part, be the result of lithium's risk of toxicity. A lower serum lithium concentration would decrease the risk of toxicity. This study examined whether lithium serum concentrations are associated with an additional medication burden resulting from psychiatric polypharmacy. Methods The retrospective data of adult inpatients receiving lithium who had at least one serum lithium concen
Like
Comment
Share
